{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:30:24Z","timestamp":1789353024033,"version":"build-2803163510"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Several studies showed inconsistencies in the relationships between inflammatory rheumatic diseases (IRDs) and the risk of Parkinson's disease (PD). Therefore, we carried out a meta-analysis to investigate the associations between different IRDs and PD risk.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A comprehensive search was undertaken on PubMed, Embase, Cochrane Library, and Web of Science databases up to June 2022. Studies reporting the relationships between IRDs and PD risk were included. Pooled relative risks (RRs) with 95% confidence intervals (CIs) were calculated by using random-effects models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-two publications covering seven IRDs containing data from 833,004 patients were identified for quantitative analysis. The pooled results indicated that ankylosing spondylitis (RR = 1.55, 95% CI: 1.31\u20131.83, I<jats:sup>2<\/jats:sup> = 32.1%, <jats:italic>P<\/jats:italic> &amp;lt; 0.001), Sj\u00f6gren's syndrome (RR = 1.34, 95% CI: 1.22\u20131.47, I<jats:sup>2<\/jats:sup> = 58.5%, <jats:italic>P<\/jats:italic> &amp;lt; 0.001), and Behcet's disease (RR = 1.93, 95% CI: 1.07\u20133.49, I<jats:sup>2<\/jats:sup> = 57.6%, <jats:italic>P<\/jats:italic> = 0.030) were associated with an increased PD risk. However, no significant associations were observed between gout, rheumatoid arthritis, systemic lupus erythematosus, as well as polymyalgia rheumatica and the subsequent development of PD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Ankylosing spondylitis, Sj\u00f6gren's syndrome, and Behcet's disease may increase PD risk.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.999820","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T05:41:00Z","timestamp":1668058860000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Inflammatory rheumatic diseases and the risk of Parkinson's disease: A systematic review and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Lili","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hecong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","article-title":"Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy","volume":"32","author":"Obeso","year":"2017","journal-title":"Mov Disord."},{"key":"B3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/bmb\/ldn013","article-title":"A review of Parkinson's disease","volume":"86","author":"Davie","year":"2008","journal-title":"Br Med Bull."},{"key":"B5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/mds.27577","article-title":"The association between lifestyle factors and Parkinson's disease progression and mortality","volume":"34","author":"Paul","year":"2019","journal-title":"Mov Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging."},{"key":"B7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system \u2014 associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat Rev Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"836119","DOI":"10.3389\/fimmu.2021.836119","article-title":"Editorial: Recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases","volume":"12","author":"Saas","year":"2021","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1759720x20962692","DOI":"10.1177\/1759720X20962692","article-title":"Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents","volume":"13","author":"Fernandez-Gutierrez","year":"2021","journal-title":"Ther Adv Musculoskelet Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s12026-014-8565-5","article-title":"New treatments for inflammatory rheumatic disease","volume":"60","author":"Selmi","year":"2014","journal-title":"Immunol Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.autrev.2017.10.011","article-title":"Rheumatic diseases and autoimmune vascular dementia","volume":"16","author":"Atzeni","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.2174\/1568026618666180516100805","article-title":"Associations between depressive disorders and inflammatory rheumatic diseases","volume":"18","author":"Varan","year":"2018","journal-title":"Curr Top Med Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1161\/STROKEAHA.115.012052","article-title":"Cerebrovascular disease in rheumatic diseases: a systematic review and meta-analysis","volume":"47","author":"Wiseman","year":"2016","journal-title":"Stroke."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.mayocp.2016.06.023","article-title":"Reduced risk of parkinson disease in patients with rheumatoid arthritis: a nationwide population-based study","volume":"91","author":"Sung","year":"2016","journal-title":"Mayo Clin Proc."},{"key":"B15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000333222","article-title":"Subsequent risks of Parkinson disease in patients with autoimmune and related disorders: a nationwide epidemiological study from Sweden","volume":"10","author":"Li","year":"2012","journal-title":"Neurodegenerative Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3233\/JPD-202418","article-title":"Decreased risk of parkinson's disease after rheumatoid arthritis diagnosis: a nested case-control study with matched cases and controls","volume":"11","author":"Bacelis","year":"2021","journal-title":"J Parkinson's Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10654-013-9791-1","article-title":"Gout and the risk of Parkinson's disease in Denmark","volume":"28","author":"Schernhammer","year":"2013","journal-title":"Eur J Epidemiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-020-01916-9","article-title":"Risk of Parkinson's disease following gout: a population-based retrospective cohort study in Taiwan","volume":"20","author":"Hu","year":"2020","journal-title":"Bmc Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol."},{"key":"B21","volume-title":"Methods Guide for Effectiveness and Comparative Effectiveness Reviews","year":"2008"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/oxfordjournals.epirev.a036298","article-title":"Quantitative methods in the review of epidemiologic literature","volume":"9","author":"Greenland","year":"1987","journal-title":"Epidemiol Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ."},{"key":"B24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/07853890.2017.1412088","article-title":"Autoimmune rheumatic diseases and the risk of Parkinson disease: a nationwide population-based cohort study in Taiwan","volume":"50","author":"Chang","year":"2018","journal-title":"Ann Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1212\/WNL.0b013e3181c06635","article-title":"Autoimmune disease and risk for Parkinson disease: A population-based case-control study","volume":"73","author":"Rugbjerg","year":"2009","journal-title":"Neurology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1212\/01.wnl.0000279518.10072.df","article-title":"Gout and risk of Parkinson disease - A prospective study","volume":"69","author":"Alonso","year":"2007","journal-title":"Neurology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/art.24193","article-title":"Gout and the risk of Parkinson's disease: a cohort study","volume":"59","author":"De Vera","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijge.2013.01.006","article-title":"Gout and Parkinson's disease in older people: an observation in Taiwan","volume":"8","author":"Lai","year":"2014","journal-title":"Int J Gerontol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e2097","DOI":"10.1097\/MD.0000000000002097","article-title":"Inverse association of Parkinson disease with systemic lupus erythematosus a nationwide population-based study","volume":"94","author":"Liu","year":"2015","journal-title":"Medicine (United States)."},{"key":"B30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12883-015-0273-9","article-title":"Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies","volume":"15","author":"Pakpoor","year":"2015","journal-title":"BMC Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0175836","DOI":"10.1371\/journal.pone.0175836","article-title":"Impact of Sjogren's syndrome on Parkinson's disease: A nationwide case-control study","volume":"12","author":"Wu","year":"2017","journal-title":"PLoS One."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e14984","DOI":"10.1097\/MD.0000000000014984","article-title":"Risk of Parkinson disease in Sj\u00f6gren syndrome administered ineffective immunosuppressant therapies: A nationwide population-based study","volume":"98","author":"Ju","year":"2019","journal-title":"Medicine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12883-018-1234-x","article-title":"Gout and the risk of Parkinson's disease in older adults: a study of U.S. Medicare data","volume":"19","author":"Singh","year":"2019","journal-title":"BMC Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s10067-020-05053-z","article-title":"Higher risk of Parkinson disease in patients with primary Sj\u00f6gren's syndrome","volume":"39","author":"Hsu","year":"2020","journal-title":"Clin Rheumatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02629-w","article-title":"Positive association of Parkinson's disease with ankylosing spondylitis: a nationwide population-based study","volume":"18","author":"Yeh","year":"2020","journal-title":"J Transl Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3390\/medicina57121292","article-title":"Clinical Association between Gout and Parkinson's Disease: A Nationwide Population-Based Cohort Study in Korea","volume":"57","author":"Kim","year":"2021","journal-title":"Medicina"},{"key":"B37","doi-asserted-by":"publisher","first-page":"105402","DOI":"10.1016\/j.jbspin.2022.105402","article-title":"Risk of Parkinson's disease in a gout Mediterranean population: A case-control study","volume":"89","author":"Pou","year":"2022","journal-title":"Joint Bone Spine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"106325","DOI":"10.1016\/j.phrs.2022.106325","article-title":"TNF inhibitors have a protective role in the risk of dementia in patients with ankylosing spondylitis: Results from a nationwide study","volume":"182","author":"Watad","year":"2022","journal-title":"Pharmacol Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3233\/JPD-212878","article-title":"Ankylosing Spondylitis: A Risk Factor for Parkinsonism-A Nationwide Population-Based Study","volume":"12","author":"Yoon","year":"2022","journal-title":"J Parkinsons Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3233\/JPD-191622","article-title":"Risk for Parkinson's disease in patients with Behcet's disease: a nationwide population-based dynamic cohort study in Korea","volume":"9","author":"Park","year":"2019","journal-title":"J Parkinsons Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fneur.2019.00122","article-title":"Inflammation, infectious triggers, and Parkinson's disease","volume":"10","author":"Caggiu","year":"2019","journal-title":"Front Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11926-019-0870-5","article-title":"Inflammation and the central nervous system in inflammatory rheumatic disease","volume":"21","author":"Kaplan","year":"2019","journal-title":"Curr Rheumatol Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"key":"B44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson's disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl Neurodegener."},{"key":"B45","doi-asserted-by":"publisher","first-page":"436813","DOI":"10.4061\/2011\/436813","article-title":"Parkinson's disease and systemic inflammation","volume":"2011","author":"Ferrari","year":"2011","journal-title":"Parkinsons Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.neuroscience.2020.08.004","article-title":"NLRP3 Inflammasomes in Parkinson's disease and their Regulation by Parkin","volume":"446","author":"Yan","year":"2020","journal-title":"Neuroscience."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4293071","DOI":"10.1155\/2020\/4293071","article-title":"What and How Can Physical Activity Prevention Function on Parkinson's Disease?","volume":"2020","author":"Fan","year":"2020","journal-title":"Oxid Med Cell Longev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.parkreldis.2015.08.030","article-title":"Gout is not associated with a lower risk of Parkinson's disease: A systematic review and meta-analysis","volume":"21","author":"Ungprasert","year":"2015","journal-title":"Parkinsonism Relat Disord."},{"key":"B49","doi-asserted-by":"publisher","first-page":"885179","DOI":"10.3389\/fneur.2022.885179","article-title":"association between rheumatoid arthritis and risk of Parkinson's disease: a meta-analysis and systematic review","volume":"13","author":"Li","year":"2022","journal-title":"Front Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1756-6606-2-5","article-title":"Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo","volume":"2","author":"Cullen","year":"2009","journal-title":"Mol Brain."},{"key":"B51","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrm3565","article-title":"Signals from the lysosome: a control centre for cellular clearance and energy metabolism","volume":"14","author":"Settembre","year":"2013","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41573-019-0036-1","article-title":"Lysosomes as a therapeutic target","volume":"18","author":"Bonam","year":"2019","journal-title":"Nat Rev Drug Discov."},{"key":"B53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41531-021-00166-x","article-title":"Rheumatoid arthritis decreases risk for Parkinson's disease: a Mendelian randomization study","volume":"7","author":"Li","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"Cd008454","DOI":"10.1002\/14651858.CD008454.pub2","article-title":"Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies","volume":"2011","author":"Rees","year":"2011","journal-title":"Cochrane Database Syst Rev."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.999820\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T05:41:03Z","timestamp":1668058863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.999820\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":54,"alternative-id":["10.3389\/fneur.2022.999820"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.999820","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"article-number":"999820"}}